◀ Back to IL3
EGR1 — IL3
Text-mined interactions from Literome
DU et al., Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008
:
It is concluded that these in vitro data provide an experimental basis for the use of gene therapy of
hematopoietic growth factor gene
regulated by
Egr-1 promoter to protect hematopoiesis from ADM-injury
DU et al., Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009
:
This study was purposed to investigate the effect of
hematopoietic growth factor expression
regulated by
Egr-1 promoter on the recovery of hematopoietic function in bearing-melanoma mice after chemotherapy with doxorubicin ( ADM )
Du et al., Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2009
:
The therapy of
hematopoietic growth factor gene
regulated by
Egr-1 promoter can protect hematopoiesis from 5-Fu injury
Du et al., Zhonghua Yi Xue Za Zhi 2009
:
These in vitro data provide an experimental basis for use of gene therapy of
hematopoietic growth factor gene
regulated by
Egr-1 promoter to protect hematopoiesis from 5-Fu-injury effects
Koyano-Nakagawa et al., Mol Cell Biol 1994
:
EGR1 and EGR2
increased IL-3 promoter activity when the transfected cells were stimulated with phorbol-12-myristate-13-acetate and A23187
Sakamoto et al., Mol Cell Biol 1994
:
Both GM-CSF and
IL-3 rapidly and transiently
induce expression of
early growth response gene 1 (egr-1) in the human factor dependent cell line TF-1
Liu et al., Cell Growth Differ 1993
(Carcinoma, Hepatocellular...) :
Other similar cytokines were investigated, and, of these, only
interleukin 1 could
increase both
Egr-1 and LDL receptor activity